Logo image of LNA.PA

LNA SANTE (LNA.PA) Stock Fundamental Analysis

EPA:LNA - Euronext Paris - Matif - FR0004170017 - Common Stock - Currency: EUR

25.7  -0.1 (-0.39%)

Fundamental Rating

4

LNA gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 25 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of LNA while its profitability can be described as average. LNA scores decently on growth, while it is valued quite cheap. This could make an interesting combination.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

LNA had positive earnings in the past year.
LNA had a positive operating cash flow in the past year.
In the past 5 years LNA has always been profitable.
LNA had a positive operating cash flow in each of the past 5 years.
LNA.PA Yearly Net Income VS EBIT VS OCF VS FCFLNA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M

1.2 Ratios

With a Return On Assets value of 1.42%, LNA is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
LNA has a Return On Equity (6.95%) which is comparable to the rest of the industry.
LNA has a Return On Invested Capital (3.65%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for LNA is below the industry average of 5.78%.
Industry RankSector Rank
ROA 1.42%
ROE 6.95%
ROIC 3.65%
ROA(3y)1.56%
ROA(5y)1.35%
ROE(3y)7.9%
ROE(5y)7.74%
ROIC(3y)3.69%
ROIC(5y)3.39%
LNA.PA Yearly ROA, ROE, ROICLNA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

LNA has a Profit Margin of 2.70%. This is comparable to the rest of the industry: LNA outperforms 56.00% of its industry peers.
LNA's Profit Margin has declined in the last couple of years.
The Operating Margin of LNA (8.28%) is better than 76.00% of its industry peers.
In the last couple of years the Operating Margin of LNA has declined.
With an excellent Gross Margin value of 89.45%, LNA belongs to the best of the industry, outperforming 88.00% of the companies in the same industry.
In the last couple of years the Gross Margin of LNA has remained more or less at the same level.
Industry RankSector Rank
OM 8.28%
PM (TTM) 2.7%
GM 89.45%
OM growth 3Y0.38%
OM growth 5Y-4.37%
PM growth 3Y-7.43%
PM growth 5Y-7.27%
GM growth 3Y1.46%
GM growth 5Y0.83%
LNA.PA Yearly Profit, Operating, Gross MarginsLNA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

2

2. Health

2.1 Basic Checks

LNA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for LNA remains at a similar level compared to 1 year ago.
LNA has more shares outstanding than it did 5 years ago.
LNA has a better debt/assets ratio than last year.
LNA.PA Yearly Shares OutstandingLNA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
LNA.PA Yearly Total Debt VS Total AssetsLNA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

LNA has an Altman-Z score of 0.95. This is a bad value and indicates that LNA is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of 0.95, LNA is not doing good in the industry: 68.00% of the companies in the same industry are doing better.
LNA has a debt to FCF ratio of 7.86. This is a slightly negative value and a sign of low solvency as LNA would need 7.86 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.86, LNA is in the better half of the industry, outperforming 68.00% of the companies in the same industry.
A Debt/Equity ratio of 2.19 is on the high side and indicates that LNA has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.19, LNA is doing worse than 76.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 2.19
Debt/FCF 7.86
Altman-Z 0.95
ROIC/WACC0.94
WACC3.86%
LNA.PA Yearly LT Debt VS Equity VS FCFLNA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.3 Liquidity

A Current Ratio of 0.91 indicates that LNA may have some problems paying its short term obligations.
Looking at the Current ratio, with a value of 0.91, LNA is in line with its industry, outperforming 52.00% of the companies in the same industry.
A Quick Ratio of 0.47 indicates that LNA may have some problems paying its short term obligations.
The Quick ratio of LNA (0.47) is worse than 88.00% of its industry peers.
Industry RankSector Rank
Current Ratio 0.91
Quick Ratio 0.47
LNA.PA Yearly Current Assets VS Current LiabilitesLNA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

The earnings per share for LNA have decreased by -6.83% in the last year.
LNA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.23% yearly.
LNA shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 9.58%.
LNA shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.85% yearly.
EPS 1Y (TTM)-6.83%
EPS 3Y-4.5%
EPS 5Y-0.23%
EPS Q2Q%-17.9%
Revenue 1Y (TTM)9.58%
Revenue growth 3Y5.37%
Revenue growth 5Y8.85%
Sales Q2Q%11.97%

3.2 Future

Based on estimates for the next years, LNA will show a very strong growth in Earnings Per Share. The EPS will grow by 21.47% on average per year.
Based on estimates for the next years, LNA will show a small growth in Revenue. The Revenue will grow by 5.87% on average per year.
EPS Next Y21.48%
EPS Next 2Y21.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year12.37%
Revenue Next 2Y10.03%
Revenue Next 3Y5.87%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
LNA.PA Yearly Revenue VS EstimatesLNA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M
LNA.PA Yearly EPS VS EstimatesLNA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

8

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 12.07, the valuation of LNA can be described as correct.
LNA's Price/Earnings ratio is a bit cheaper when compared to the industry. LNA is cheaper than 80.00% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.69. LNA is valued rather cheaply when compared to this.
A Price/Forward Earnings ratio of 9.37 indicates a reasonable valuation of LNA.
Based on the Price/Forward Earnings ratio, LNA is valued cheaply inside the industry as 84.00% of the companies are valued more expensively.
LNA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 37.36.
Industry RankSector Rank
PE 12.07
Fwd PE 9.37
LNA.PA Price Earnings VS Forward Price EarningsLNA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, LNA is valued cheaper than 88.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, LNA is valued cheaply inside the industry as 92.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.8
EV/EBITDA 5.57
LNA.PA Per share dataLNA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as LNA's earnings are expected to grow with 21.47% in the coming years.
PEG (NY)0.56
PEG (5Y)N/A
EPS Next 2Y21.47%
EPS Next 3YN/A

6

5. Dividend

5.1 Amount

LNA has a Yearly Dividend Yield of 2.52%.
LNA's Dividend Yield is a higher than the industry average which is at 2.87.
LNA's Dividend Yield is comparable with the S&P500 average which is at 2.34.
Industry RankSector Rank
Dividend Yield 2.52%

5.2 History

The dividend of LNA is nicely growing with an annual growth rate of 9.57%!
Dividend Growth(5Y)9.57%
Div Incr Years3
Div Non Decr Years3
LNA.PA Yearly Dividends per shareLNA.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

28.13% of the earnings are spent on dividend by LNA. This is a low number and sustainable payout ratio.
LNA's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.13%
EPS Next 2Y21.47%
EPS Next 3YN/A
LNA.PA Yearly Income VS Free CF VS DividendLNA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
LNA.PA Dividend Payout.LNA.PA Dividend Payout, showing the Payout Ratio.LNA.PA Dividend Payout.PayoutRetained Earnings

LNA SANTE

EPA:LNA (7/24/2025, 10:55:33 AM)

25.7

-0.1 (-0.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)N/A N/A
Earnings (Next)07-24 2025-07-24
Inst Owners9.59%
Inst Owner ChangeN/A
Ins Owners1%
Ins Owner ChangeN/A
Market Cap275.25M
Analysts85
Price Target31.82 (23.81%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.52%
Yearly Dividend0.6
Dividend Growth(5Y)9.57%
DP28.13%
Div Incr Years3
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.26%
PT rev (3m)-3.26%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.71%
Valuation
Industry RankSector Rank
PE 12.07
Fwd PE 9.37
P/S 0.34
P/FCF 2.8
P/OCF 2.49
P/B 0.88
P/tB N/A
EV/EBITDA 5.57
EPS(TTM)2.13
EY8.29%
EPS(NY)2.74
Fwd EY10.67%
FCF(TTM)9.18
FCFY35.71%
OCF(TTM)10.31
OCFY40.12%
SpS75.31
BVpS29.3
TBVpS-24.71
PEG (NY)0.56
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.42%
ROE 6.95%
ROCE 5.93%
ROIC 3.65%
ROICexc 3.89%
ROICexgc 7.89%
OM 8.28%
PM (TTM) 2.7%
GM 89.45%
FCFM 12.18%
ROA(3y)1.56%
ROA(5y)1.35%
ROE(3y)7.9%
ROE(5y)7.74%
ROIC(3y)3.69%
ROIC(5y)3.39%
ROICexc(3y)3.98%
ROICexc(5y)3.73%
ROICexgc(3y)8.5%
ROICexgc(5y)8.01%
ROCE(3y)5.91%
ROCE(5y)5.67%
ROICexcg growth 3Y1.6%
ROICexcg growth 5Y1.57%
ROICexc growth 3Y2.72%
ROICexc growth 5Y-1.59%
OM growth 3Y0.38%
OM growth 5Y-4.37%
PM growth 3Y-7.43%
PM growth 5Y-7.27%
GM growth 3Y1.46%
GM growth 5Y0.83%
F-Score5
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 2.19
Debt/FCF 7.86
Debt/EBITDA 4.33
Cap/Depr 13.25%
Cap/Sales 1.51%
Interest Coverage 2.34
Cash Conversion 69.64%
Profit Quality 450.48%
Current Ratio 0.91
Quick Ratio 0.47
Altman-Z 0.95
F-Score5
WACC3.86%
ROIC/WACC0.94
Cap/Depr(3y)14.64%
Cap/Depr(5y)16.09%
Cap/Sales(3y)1.69%
Cap/Sales(5y)1.89%
Profit Quality(3y)386.77%
Profit Quality(5y)628.45%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.83%
EPS 3Y-4.5%
EPS 5Y-0.23%
EPS Q2Q%-17.9%
EPS Next Y21.48%
EPS Next 2Y21.47%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)9.58%
Revenue growth 3Y5.37%
Revenue growth 5Y8.85%
Sales Q2Q%11.97%
Revenue Next Year12.37%
Revenue Next 2Y10.03%
Revenue Next 3Y5.87%
Revenue Next 5YN/A
EBIT growth 1Y5.74%
EBIT growth 3Y5.76%
EBIT growth 5Y4.09%
EBIT Next Year146.2%
EBIT Next 3Y35.02%
EBIT Next 5YN/A
FCF growth 1Y16.06%
FCF growth 3Y14.06%
FCF growth 5Y-2.49%
OCF growth 1Y13.27%
OCF growth 3Y11.38%
OCF growth 5Y-1.32%